An eye-catching South Bay office building that was once the headquarters of bankrupt biotech company 23andMe has been bought at a price that reflects a massive decline in the property's value. The ...

Take a fascinating look back at the science and technology advances that shaped medicine’s past and will define its future.

A long shot provision in President Donald Trump’s budget bill raises questions about whether proposed court limits would ...

I wrote about a new company called 23andMe, which would take a sample of your DNA and tell you all sorts of interesting stuff ...

The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

The company’s board of directors negotiates the deal with the controlling shareholder, and has fiduciary ...

After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...

Me wants to reopen bidding on its assets after former CEO Anne Wojcicki put together a $305 million offer, topping Regeneron.

Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...

Me (OTC:MEHCQ) faces a second auction after a $305M bid challenges Regeneron's (REGN) initial bid for its assets. Read more ...